These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 53067)

  • 41. [Differences in the occurrence and changes in mast cells in cervix dysplasia and carcinoma in situ].
    Opacki W
    Ginekol Pol; 1986 Jan; 57(1):56-63. PubMed ID: 3721270
    [No Abstract]   [Full Text] [Related]  

  • 42. A RADIOAUTOGRAPHIC ANALYSIS OF CELLULAR PROLIFERATION IN DYSPLASIA AND CARCINOMA IN SITU OF THE UTERINE CERVIX.
    RICHART RM
    Am J Obstet Gynecol; 1963 Aug; 86():925-30. PubMed ID: 14047515
    [No Abstract]   [Full Text] [Related]  

  • 43. Dysplasia and cancer in situ of young patients: colposcopic and cytological observations.
    Bauer H
    J Reprod Med; 1974 May; 12(5):205-6. PubMed ID: 4838314
    [No Abstract]   [Full Text] [Related]  

  • 44. [Histology of premalignant changes in the cervix uteri].
    Torhorst J
    Gynakologe; 1981 Dec; 14(4):199-203. PubMed ID: 7033079
    [No Abstract]   [Full Text] [Related]  

  • 45. [Histological nomenclature and classification of benign epithelial changes in the cervix uteri and of pre- and early stages of cervix carcinoma].
    Büttner HH; Kyank H; Bader G
    Zentralbl Gynakol; 1974 Aug; 96(31):461-8. PubMed ID: 4471673
    [No Abstract]   [Full Text] [Related]  

  • 46. [Histological studies on the topography in dysplasia and carcinoma in situ of the extocervix (author's transl)].
    Bader G; Büttner HH; Neumann HG
    Zentralbl Allg Pathol; 1974; 118(6):501-3. PubMed ID: 4466212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The occurrence of isolated dysplastic and carcinoma in situ type cells in cervical smears from patients with dysplasia and carcinoma in situ: significance to prescreening using image processing techniques.
    Feldman M; Poulsen R; Shepherd L; Marshall KG
    Acta Cytol; 1973; 17(5):395-400. PubMed ID: 4517951
    [No Abstract]   [Full Text] [Related]  

  • 48. [A comparison of cytological and histological studies on women with a colposcopically atypical cervix uteri].
    Zamfirova K; Zlatkov V; Makaveeva V
    Akush Ginekol (Sofiia); 1990; 29(5):27-30. PubMed ID: 2091471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intraepithelial neoplasia of the cervix].
    Ricaud Rothiot L; Hernández Arvízu JE; Villalobos Román M
    Ginecol Obstet Mex; 1984 Dec; 52(332):285-303. PubMed ID: 6397410
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of induced interferon upon cells of cervical carcinoma in situ.
    Ayre JE; Narvaez R; LoGerfo JJ
    Oncology; 1973; 27(2):108-17. PubMed ID: 4121814
    [No Abstract]   [Full Text] [Related]  

  • 51. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri.
    Christopherson WM; Nealon N; Gray LA
    Cancer; 1979 Sep; 44(3):975-83. PubMed ID: 476603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Histopathological pictures of sections of the cervix uteri in Papanicolau cytograms III, IV and V].
    Danilewicz M; Tuka E; Wagrowska-Danilewicz M
    Patol Pol; 1985; 36(3):237-44. PubMed ID: 3835508
    [No Abstract]   [Full Text] [Related]  

  • 53. [Foundations for differential cytology of cervical changes. 3. Dysplasia and carcinoma in situ (author's transl)].
    Höffken H; Rummel HH
    Zentralbl Gynakol; 1981; 103(24):1517-36. PubMed ID: 7340303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carcinoma-in-situ of the cervix and vulval warts complicating malignant lymphoma.
    el-Maraghy MA; Lamki H; Pinkerton JH; Mawhinney H
    Ir Med J; 1978 Mar; 71(5):159-61. PubMed ID: 649319
    [No Abstract]   [Full Text] [Related]  

  • 55. [Complete and incomplete removal of precancerous conditions by conization].
    Kraus H; Schuhmann RA; Breinl H
    Fortschr Med; 1983 Oct; 101(39):1762-5. PubMed ID: 6642381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
    Ishiguro T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic deletion in cervical neoplasia.
    Ashley C; Kirkland JA; Stanley MA
    Pathology; 1974 Oct; 6(4):329-35. PubMed ID: 4615290
    [No Abstract]   [Full Text] [Related]  

  • 58. Premalignant lesions of the cervix in women of Cali, Colombia.
    Duque E; Cuello C; Aristizábal N; Haenszel W; Botero S; Correa P
    J Natl Cancer Inst; 1979 Oct; 63(4):953-63. PubMed ID: 480388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
    Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
    Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cytomorphologic and morphometric characteristics of the endocervical epithelium during malignant degeneration].
    Novik VI; Agroskin LS; Solov'eva LV
    Vopr Onkol; 1989; 35(6):715-21. PubMed ID: 2750084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.